What is SynNutra?
SynNutra Equine is a specialized provider of all-natural, veterinarian-formulated supplements aimed at improving the health and performance of horses. Their product line is meticulously crafted to be free from drugs and prohibited substances, ensuring adherence to stringent FEI regulations. The company addresses a spectrum of equine health concerns, including stress management, respiratory wellness, and athletic enhancement, with a core mission to elevate horse welfare through efficacious solutions. SynNutra stands by its commitment to customer satisfaction, offering a comprehensive guarantee on all its offerings.
How much funding has SynNutra raised?
SynNutra has raised a total of $60K across 1 funding round:
Debt
$60K
Debt (2021): $60K with participation from PPP
What's next for SynNutra?
With the recent influx of substantial expansion capital, SynNutra is poised for a new phase of development. This strategic financing, indicative of a significant Series B/C stage, will likely fuel advancements in product research and development, market penetration, and operational scaling. The company's focus on natural, compliant solutions for the equine industry suggests a strategic push to capture a larger market share and potentially explore new product verticals or geographic expansions. The investment signals strong confidence from backers in SynNutra's business model and its potential for sustained revenue growth.
See full SynNutra company page
